The drug 2-deoxy-D-glucose (2-DG) formulated by DRDO has been approved by the Drug Controller General of India amidst the havoc of Corona across the country. Along with this, DRDO is building hospitals in the most corona infected parts of the country. At the same time, DRDO teams are constantly making all efforts to save the lives of the countrymen in this era of epidemics. Amidst all this, DRDO has designed OxyCare system to eliminate the lack of oxygen in the country. An excellent decision has been taken by the Central Government to take this step further by DRDO.
After the anti-covid drug, now the Defense Research and Development Organization has fully prepared to solve the oxygen problem of the patients. After this DRDO’s Oxycare System Discovery has been approved for purchase through PM Care Fund. DRDO may soon start its supply process. This information has been provided by DRDO.
According to the news, to overcome the oxygen shortage, the purchase of 1 lakh 50 thousand units of Oxycare system prepared by the DRDO has been approved from the PM Cares Fund. The price of this oxycare system is being said to be Rs 322.5 crores. It is a SpO2-based oxygen supply system, which regulates oxygen, delivering oxygen to the patient based on the SpO2 level.
